Abstract

BENEFIT OVER RISK OF USING CHLOROQUINE AND HYDROXYCHLOROQUINE IN COVID – 19 PATIENTS

Purushottam Ghosh*

Abstract

The increasing mortality rate across the world lead the medical professionals to find alternatives to curve down the deceased rate and the spread the novel coronavirus pandemic however the potential vaccination for the said virus might need some more time to develop. Recently many studies were conducted on the benefit of chloroquine and hydroxychloroquine in the prevention and management of COVID-19. Moreover the evidence of safety profile of these drugs in COVID-19 patients is very weak due to lack of clinical trials. However, most studies did not address the clinically associated side effects and toxicity associated with both the drugs. This article provides a brief note on its potential side effects that might arise during the medical therapy of the COVID-19 patients.

Keywords: coronavirus, chloroquine, hydroxychloroquine, COVID-19.